Drugs / LX102-C01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05831007 | Dec 2021 → Jun 2023 | wet macular degeneration | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX102-C01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831007 ↗ |
| Route | Intravitreal | “single unilateral intravitreal injection of LX102-C01” NCT05831007 ↗ |